ILMN stock · KTTAW stock

ILMN vs KTTAW

Illumina Inc (ILMN) versus Pasithea Therapeutics Corp. Warrant (KTTAW) — a side-by-side from cached financials, not a winner call.

Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..

Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.

Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.

KTTAW does not have a complete income-statement cache yet.

ILMN currently screens at market cap $15.84B. KTTAW currently screens at market cap $0.

Not investment advice. Open the ILMN and KTTAW stock pages for the full models.

Not investment advice.

Popular Stock Comparisons